 Research Design
"Research Design" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
| Descriptor ID |
D012107
|
| MeSH Number(s) |
E05.581.500 H01.770.644.728
|
| Concept/Terms |
Research Design- Research Design
- Design, Research
- Designs, Research
- Research Designs
Problem Formulation- Problem Formulation
- Formulation, Problem
- Formulations, Problem
- Problem Formulations
Research Proposal- Research Proposal
- Proposal, Research
- Proposals, Research
- Research Proposals
Scoring Methods- Scoring Methods
- Method, Scoring
- Methods, Scoring
- Scoring Method
Matched Groups- Matched Groups
- Group, Matched
- Groups, Matched
- Matched Group
Error Sources- Error Sources
- Error Source
- Source, Error
- Sources, Error
Data Quality- Data Quality
- Data Qualities
- Qualities, Data
- Quality, Data
Experimental Design- Experimental Design
- Designs, Experimental
- Experimental Designs
- Design, Experimental
|
Below are MeSH descriptors whose meaning is more general than "Research Design".
Below are MeSH descriptors whose meaning is more specific than "Research Design".
This graph shows the total number of publications written about "Research Design" by people in UCSF Profiles by year, and whether "Research Design" was a major or minor topic of these publication.
Below are the most recent publications written about "Research Design" by people in Profiles.
-
Chen CE, Dhruva SS, Redberg RF. Inclusion of comparative effectiveness data in high-risk cardiovascular device studies at the time of premarket approval. JAMA. 2012 Nov 7; 308(17):1740-2.
-
Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012 Oct 11; 490(7419):187-91.
-
Teresi JA, Stewart AL, Stahl SM. Fifteen years of progress in measurement and methods at the resource centers for minority aging research. J Aging Health. 2012 Sep; 24(6):985-91.
-
Ye Y, Bond JC, Schmidt LA, Mulia N, Tam TW. Toward a better understanding of when to apply propensity scoring: a comparison with conventional regression in ethnic disparities research. Ann Epidemiol. 2012 Oct; 22(10):691-7.
-
Keizer RJ, Gupta A, Shumaker R, Beijnen JH, Schellens JH, Huitema AD. Model-based treatment optimization of a novel VEGFR inhibitor. Br J Clin Pharmacol. 2012 Aug; 74(2):315-26.
-
de Carvalho EC, Batilana AP, Claudino W, Reis LF, Schmerling RA, Shah J, Pietrobon R. Workflow in clinical trial sites & its association with near miss events for data quality: ethnographic, workflow & systems simulation. PLoS One. 2012; 7(6):e39671.
-
Kohli P, Desai NR, Giugliano RP, Kim JB, Somaratne R, Huang F, Knusel B, McDonald S, Abrahamsen T, Wasserman SM, Scott R, Sabatine MS. Design and rationale of the LAPLACE-TIMI 57 trial: a phase II, double-blind, placebo-controlled study of the efficacy and tolerability of a monoclonal antibody inhibitor of PCSK9 in subjects with hypercholesterolemia on background statin therapy. Clin Cardiol. 2012; 35(7):385-91.
-
Fisher RS, Blum DE, DiVentura B, Vannest J, Hixson JD, Moss R, Herman ST, Fureman BE, French JA. Seizure diaries for clinical research and practice: limitations and future prospects. Epilepsy Behav. 2012 Jul; 24(3):304-10.
-
Galanis E, Wu W, Cloughesy T, Lamborn K, Mann B, Wen PY, Reardon DA, Wick W, Macdonald D, Armstrong TS, Weller M, Vogelbaum M, Colman H, Sargent DJ, van den Bent MJ, Gilbert M, Chang S. Phase 2 trial design in neuro-oncology revisited: a report from the RANO group. Lancet Oncol. 2012 May; 13(5):e196-204.
-
Stewart AL, Thrasher AD, Goldberg J, Shea JA. A framework for understanding modifications to measures for diverse populations. J Aging Health. 2012 Sep; 24(6):992-1017.
|
People People who have written about this concept. _
Related Concepts
People who have written about this concept.
_
Top journals in which articles about this concept have been published.
|
